This year's annual report from the National Committee for Quality Assurance showed a mixed bag of good and bad news, reported Managed Care (11/2005). Of the 289 commercial health plans that reported data to the NCQA, the average performance showed improvements in 18 of 22 clinical measures.
This year's annual report from the National Committee for Quality Assurance showed a mixed bag of good and bad news, reported Managed Care (11/2005). Of the 289 commercial health plans that reported data to the NCQA, the average performance showed improvements in 18 of 22 clinical measures. First the bad news: The average performance of the health plans worsened with respect to breast cancer screening. On the other hand, the clinical measures that did show improvement included beta-blocker treatment after a heart attack, comprehensive diabetes care, cholesterol management control, high blood pressure control, and childhood immunization status.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More